Biotechnology Research
Boston, Massachusetts
11-50 employees
Founded 2021
About Valink Therapeutics
Valink Therapeutics is a biotechnology company dedicated to discovering next-generation therapies for cancer. It provides a rapid, modular protein technology platform for the efficient construction and high-throughput screening of advanced antibody-based therapeutics, including bispecific antibody-drug conjugates (bsADCs). The company partners with pharmaceutical companies, biotech firms, and research organizations to accelerate the development of novel cancer treatments.
Company Classification
Customer Types
B2B
Business Models
ServicesLicensing
Product & Service Types
Drug discovery platformsAntibody-drug conjugate (ADC) therapeuticsPreclinical research services
Funding
Total Funding
$125.0K
No. of Funding Rounds
1
Customers
| Customer | Success Story | Source |
|---|---|---|
| Utilized Valink Therapeutics' expertise to progress programmes from discovery through clinical development. | ||
| Collaborated with Valink Therapeutics to develop multiple immune cell engager programmes from inception to pre-IND and into Phase I. |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos